New frontiers in immune checkpoint B7-H3 (CD276) research and drug development

被引:0
|
作者
Ayechew Adera Getu
Abiye Tigabu
Ming Zhou
Jianrong Lu
Øystein Fodstad
Ming Tan
机构
[1] Institute of Biochemistry and Molecular Biology,Department of Physiology, School of Medicine, College of Medicine and Health Sciences
[2] Institute of Biomedical Sciences,Department of Biochemistry and Molecular Biology, College of Medicine
[3] and Research Center for Cancer Biology,undefined
[4] China Medical University,undefined
[5] University of Gondar,undefined
[6] Cancer Research Institute and School of Basic Medical Sciences,undefined
[7] Central South University,undefined
[8] University of Florida,undefined
[9] Department of Tumor Biology,undefined
[10] Institute for Cancer Research,undefined
[11] Oslo University Hospital Radiumhospitalet,undefined
来源
关键词
B7-H3; CD276; Cancer; Immunotherapy; Drug Development;
D O I
暂无
中图分类号
学科分类号
摘要
B7-H3 (CD276), a member of the B7 family of proteins, is a key player in cancer progression. This immune checkpoint molecule is selectively expressed in both tumor cells and immune cells within the tumor microenvironment. In addition to its immune checkpoint function, B7-H3 has been linked to tumor cell proliferation, metastasis, and therapeutic resistance. Furthermore, its drastic difference in protein expression levels between normal and tumor tissues suggests that targeting B7-H3 with drugs would lead to cancer-specific toxicity, minimizing harm to healthy cells. These properties make B7-H3 a promising target for cancer therapy.
引用
收藏
相关论文
共 50 条
  • [21] Stimulation of B7-H3 (CD276) directs the differentiation of human marrow stromal cells to osteoblasts
    Xu, Lan
    Zhang, Guangbo
    Zhou, Yinghui
    Chen, Yongjing
    Xu, Wei
    Wu, Shiliang
    Zhang, Xueguang
    IMMUNOBIOLOGY, 2011, 216 (12) : 1311 - 1317
  • [22] Expression of B7-H3 (CD276) in surgically resected esophageal squamous cell carcinoma.
    Maruki, Yuta
    Takashima, Atsuo
    Miyamoto, Takahiro
    Hirano, Hidekazu
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Okita, Natsuko
    Kato, Ken
    Sekine, Shigeki
    Koyanagi, Kazuo
    Daiko, Hiroyuki
    Kitano, Shigehisa
    Aoki, Kazunori
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [23] Expression and Prognostic Value of a Novel B7-H3 (CD276) Antibody in Acute Myeloid Leukemia
    Stefanczyk, Sylwia A.
    Hayn, Clara
    Heitmann, Jonas
    Jung, Susanne
    Zekri, Latifa
    Maerklin, Melanie
    CANCERS, 2024, 16 (13)
  • [24] mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
    Liu, Heng-Jia
    Du, Heng
    Khabibullin, Damir
    Zarei, Mahsa
    Wei, Kevin
    Freeman, Gordon J.
    Kwiatkowski, David J.
    Henske, Elizabeth P.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [25] Mycoplasma infection modifies attachment, proliferation, and the expression of immune checkpoint antigen CD276 (B7-H3) on the Cal29 bladder cancer cell line
    Aicher, Wilhelm K.
    FASEB JOURNAL, 2022, 36
  • [26] DECIPHERING THE FUNCTION OF THE UBIQUITIN-PROTEASOME-SYSTEM IN REGULATING THE IMMUNE CHECKPOINT PROTEIN B7-H3 (CD276) IN NON-SMALL CELL LUNG CANCER
    Kurz, M.
    Rieger, L.
    Giansanti, P.
    Kuster, B.
    Bassermann, F.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A5 - A5
  • [27] mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion
    Heng-Jia Liu
    Heng Du
    Damir Khabibullin
    Mahsa Zarei
    Kevin Wei
    Gordon J. Freeman
    David J. Kwiatkowski
    Elizabeth P. Henske
    Nature Communications, 14
  • [28] Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma
    Wang, Zhiliang
    Wang, Zheng
    Zhang, Chuanbao
    Liu, Xing
    Li, Guanzhang
    Liu, Shuai
    Sun, Lihua
    Liang, Jingshan
    Hu, Huimin
    Liu, Yanwei
    Zhang, Wei
    Jiang, Tao
    CANCER SCIENCE, 2018, 109 (09) : 2697 - 2705
  • [29] Pan-cancer associations of B7-H3 (CD276) transcriptional expression across human malignancies
    Hwang, Justin
    Zorko, Nick
    Elliott, Andrew
    Lozada, Jose A.
    Radovich, Milan
    Heath, Elisabeth I.
    Agarwal, Neeraj
    McKay, Rana R.
    Garje, Rohan
    Bastos, Bruno R.
    Hoon, Dave S. B.
    Nabhan, Chadi
    Sledge, George W.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Tumor B7-H3 (CD276) Protein Expression, Smoking History, and Survival in Lung Adenocarcinoma Patients
    Inamura, Kentaro
    Yokouchi, Yusuke
    Kobayashi, Maki
    Sakakibara, Rie
    Ninomiya, Hironori
    Subat, Sophia
    Nagano, Hiroko
    Nomura, Kimie
    Okumura, Sakae
    Shibutani, Tomoko
    Ishikawa, Yuichi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S802 - S802